Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As(2)O(3)) and all-trans retinoic acid (ATRA)

Detalles Bibliográficos
Autores principales: Jain, Preetesh, Konoplev, Sergej, Benjamini, Ohad, Romagura, Jorge, Burger, Jan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021572/
https://www.ncbi.nlm.nih.gov/pubmed/29963527
http://dx.doi.org/10.5045/br.2018.53.2.169
_version_ 1783335502842167296
author Jain, Preetesh
Konoplev, Sergej
Benjamini, Ohad
Romagura, Jorge
Burger, Jan A.
author_facet Jain, Preetesh
Konoplev, Sergej
Benjamini, Ohad
Romagura, Jorge
Burger, Jan A.
author_sort Jain, Preetesh
collection PubMed
description
format Online
Article
Text
id pubmed-6021572
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-60215722018-06-29 Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As(2)O(3)) and all-trans retinoic acid (ATRA) Jain, Preetesh Konoplev, Sergej Benjamini, Ohad Romagura, Jorge Burger, Jan A. Blood Res Letter to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2018-06 2018-06-25 /pmc/articles/PMC6021572/ /pubmed/29963527 http://dx.doi.org/10.5045/br.2018.53.2.169 Text en © 2018 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Jain, Preetesh
Konoplev, Sergej
Benjamini, Ohad
Romagura, Jorge
Burger, Jan A.
Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As(2)O(3)) and all-trans retinoic acid (ATRA)
title Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As(2)O(3)) and all-trans retinoic acid (ATRA)
title_full Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As(2)O(3)) and all-trans retinoic acid (ATRA)
title_fullStr Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As(2)O(3)) and all-trans retinoic acid (ATRA)
title_full_unstemmed Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As(2)O(3)) and all-trans retinoic acid (ATRA)
title_short Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As(2)O(3)) and all-trans retinoic acid (ATRA)
title_sort long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (as(2)o(3)) and all-trans retinoic acid (atra)
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021572/
https://www.ncbi.nlm.nih.gov/pubmed/29963527
http://dx.doi.org/10.5045/br.2018.53.2.169
work_keys_str_mv AT jainpreetesh longtermcontrolofrefractoryfollicularlymphomaaftertreatmentofsecondaryacutepromyelocyticleukemiawitharsenictrioxideas2o3andalltransretinoicacidatra
AT konoplevsergej longtermcontrolofrefractoryfollicularlymphomaaftertreatmentofsecondaryacutepromyelocyticleukemiawitharsenictrioxideas2o3andalltransretinoicacidatra
AT benjaminiohad longtermcontrolofrefractoryfollicularlymphomaaftertreatmentofsecondaryacutepromyelocyticleukemiawitharsenictrioxideas2o3andalltransretinoicacidatra
AT romagurajorge longtermcontrolofrefractoryfollicularlymphomaaftertreatmentofsecondaryacutepromyelocyticleukemiawitharsenictrioxideas2o3andalltransretinoicacidatra
AT burgerjana longtermcontrolofrefractoryfollicularlymphomaaftertreatmentofsecondaryacutepromyelocyticleukemiawitharsenictrioxideas2o3andalltransretinoicacidatra

Ejemplares similares